AU2013903573A0 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents
Compositions for the treatment of hypertension and/or fibrosisInfo
- Publication number
- AU2013903573A0 AU2013903573A0 AU2013903573A AU2013903573A AU2013903573A0 AU 2013903573 A0 AU2013903573 A0 AU 2013903573A0 AU 2013903573 A AU2013903573 A AU 2013903573A AU 2013903573 A AU2013903573 A AU 2013903573A AU 2013903573 A0 AU2013903573 A0 AU 2013903573A0
- Authority
- AU
- Australia
- Prior art keywords
- fibrosis
- hypertension
- compositions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010016654 Fibrosis Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14845373.1A EP3046901B1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
NZ717927A NZ717927A (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
RU2016112257A RU2635564C2 (en) | 2013-09-17 | 2014-09-17 | Composition for treatment of hypertension and/or fibrosis |
CA2924356A CA2924356C (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
AU2014324078A AU2014324078B2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
NO14845373A NO3046901T3 (en) | 2013-09-17 | 2014-09-17 | |
MYPI2016000482A MY172557A (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
CN201480050979.1A CN105683152B (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
US15/022,278 US9458093B2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
AP2016009079A AP2016009079A0 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
JP2016515425A JP6122548B2 (en) | 2013-09-17 | 2014-09-17 | Composition for the treatment of hypertension and / or fibrosis |
BR112016005601-9A BR112016005601B1 (en) | 2013-09-17 | 2014-09-17 | compound, pharmaceutical composition, and uses of a compound |
MX2016003371A MX368865B (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis. |
KR1020167008664A KR101736416B1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
UAA201602267A UA118111C2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
PCT/AU2014/000923 WO2015039173A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
PL14845373T PL3046901T3 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
SG11201601642WA SG11201601642WA (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
DK14845373.1T DK3046901T3 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of high blood pressure and / or fibrosis |
ES14845373.1T ES2655455T3 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and / or fibrosis |
PH12016500497A PH12016500497B1 (en) | 2013-09-17 | 2016-03-14 | Compositions for the treatment of hypertension and/or fibrosis |
IL244621A IL244621A (en) | 2013-09-17 | 2016-03-16 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2013903573A0 true AU2013903573A0 (en) | 2013-10-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3038610A4 (en) | Compositions and methods for the treatment of presbyopia | |
EP2877159B8 (en) | Efflux inhibitor compositions and methods of treatment using the same | |
EP3030266A4 (en) | Topical compositions and methods of using the same | |
EP2991658A4 (en) | Antimicrobial compositions and methods of making the same | |
EP3071215A4 (en) | Compositions and methods for treating pulmonary hypertension | |
EP3102555A4 (en) | Compositions of compounds and uses thereof | |
EP3102200A4 (en) | Therapeutic compounds and compositions | |
EP3179983A4 (en) | Anti-methanogenic compositions and uses thereof | |
EP3166892A4 (en) | Scale-inhibition compositions and methods of making and using the same | |
EP3021839A4 (en) | Methods and compositions for treatment of fibrosis | |
EP2983681A4 (en) | Therapeutic compositions and uses thereof | |
EP3013364A4 (en) | Tuberculosis compositions and methods of using the same | |
EP3004396A4 (en) | Methods and compositions for the treatment of cancer | |
IL244621A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
IL244622A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
EP3117827A4 (en) | Composition for vagina and use of the composition | |
HK1220374A1 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
EP3316871A4 (en) | Talc-bound compositions and uses thereof | |
EP3341006A4 (en) | Compositions and methods for the treatment of neurodamage | |
EP3165221A4 (en) | Blood-fat reducing composition and application thereof | |
EP3113774A4 (en) | Compositions of grapiprant and methods for using the same | |
EP3110435A4 (en) | Methods and compositions for the delayed treatment of stroke | |
EP2994147A4 (en) | Compositions and methods for the treatment of tinnitus | |
EP3038596A4 (en) | Compositions and methods for the removal of tattoos | |
EP3068431A4 (en) | Methods and compositions for the treatment of hcmv |